Published in Healthcare Mergers, Acquisitions and Ventures Week, October 9th, 2004
Janulis has more than 17 years of experience in the area of generic pharmaceutical industry regulatory affairs, specifically with Hatch-Waxman issues involving patent infringement litigation and marketing exclusivity.
Before joining Able, Janulis spent the majority of her career with the Purepac Pharmaceutical Co. division of F.H. Faulding & Co. Limited developing regulatory strategies involving patented products.
"We are excited that Joan has become an integral part of Able's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.